In this Healthed lecture, GPs, Dr Steph Daly and Dr Rebecca Moore will discuss the importance of identifying and assessing mild cognitive impairment, and how best to determine which patients are most at risk of proceeding to Alzheimer's disease. In addition they will address the role of blood biomarkers in this assessment as well as the eligibility criteria for these new medications.   

See omnystudio.com/listener for privacy information.